[1]
2025. Bioanalytical Method Development and Validation for Empagliflozin and Semaglutide: A Comparative Review. Journal of Carcinogenesis. 24, 4s (Sep. 2025), 905–913. DOI:https://doi.org/10.64149/J.Carcinog.24.4s.905-913.